Brind.

Both Zai Lab Limited and Apellis Pharmaceuticals are identified as high-growth biopharmaceutical companies.

1 report, 0 independent Updated Jul 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Both Zai Lab Limited and Apellis Pharmaceuticals are identified as high-growth biopharmaceutical companies.

Who's involved

What this event is mainly about
Zai Lab LimitedApellis Pharmaceuticals (United States)

Keep exploring

The entities involved

  • Zai Lab Limited

    Zai Lab is an innovative, research-based, commercial stage biopharmaceutical company based in China and the U.S. focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world.

    Nothing else this week.

  • Apellis Pharmaceuticals (United States)

    company in Crestwood, United States

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • Unknown outlet